[HTML][HTML] Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: the prime suspect in cancer therapeutic resistance

H Aria, M Rezaei, S Nazem, A Daraei, G Nikfar… - Frontiers in …, 2022 - frontiersin.org
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …

[HTML][HTML] Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance

H Aria, M Rezaei, S Nazem, A Daraei… - Frontiers in …, 2022 - frontiersin.org
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …

[PDF][PDF] Purinergic Receptors Are a Key Bottleneck in Tumor Metabolic Reprogramming: The Prime Suspect in Cancer Therapeutic Resistance

H Aria, M Rezaei, S Nazem, A Daraei, G Nikfar… - 2022 - scholar.archive.org
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
21 Purinergic receptors and ectonucleotidases regulate various signaling pathways that …

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance

H Aria, M Rezaei, S Nazem, A Daraei… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …

[HTML][HTML] Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance

H Aria, M Rezaei, S Nazem, A Daraei… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …

Purinergic Receptors Are a Key Bottleneck in Tumor Metabolic Reprogramming: The Prime Suspect in Cancer Therapeutic Resistance

H Aria, M Rezaei, S Nazem, A Daraei, G Nikfar… - 2022 - preprints.org
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.

H Aria, M Rezaei, S Nazem, A Daraei… - Frontiers in …, 2022 - europepmc.org
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance.

H Aria, M Rezaei, S Nazem, A Daraei… - Frontiers in …, 2022 - europepmc.org
ATP and other nucleoside phosphates have specific receptors named purinergic receptors.
Purinergic receptors and ectonucleotidases regulate various signaling pathways that play a …